12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1)

sodium;1,3,7,9-tetratert-butyl-11-hydroxy-5H-benzo[d][1,3,2]benzodioxaphosphocine 11-oxide

SynHet is professional manufacturer and supplier of 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2 and related synthetic chemical products. 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2 competitive price available in stock and short delivery time (<1 week lead time). SynHet offers 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2 >99% pure bulk and prepack quantities (USP, BP, Ph. Eur.) pharma grade, active pharmaceutical ingredient (API), ISO 9001. 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2 is analyzed by LCMS or GCMS, other analytical methods High Performance Liquid Chromatography (HPLC), Gas Chromatography (GC FID), Mass spectrometry (MS), Capillary Electrophoresis (CZE), UV Spectrophotometric (UV-VIS), Fourier-Transform Infrared Spectroscopy (FTIR), Proton/Carbon Nuclear Magnetic Resonance (NMR), Titration, CHNS Elemental Analysis are available upon request. 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1) is also known as: Product name: 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1) CAS number: 85209-91-2 PubChem ID (CID): 21125221 IUPAC name: sodium;1,3,7,9-tetratert-butyl-11-hydroxy-5H-benzo[d][1,3,2]benzodioxaphosphocine 11-oxide SMILE string: CC(C)(C)c1cc(C(C)(C)C)cc(c12)Cc3c(OP(=O)(O2)O)c(C(C)(C)C)cc(c3)C(C)(C)C.[Na+], Synonyms: 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), sodium;1,3,7,9-tetratert-butyl-11-hydroxy-5H-benzo[d][1,3,2]benzodioxaphosphocine 11-oxide, 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2 used as Pharmaceutical intermediates; Pharma material, Fine chemical, Reagents (for Synthesis), intermediate for synthesis and pharma application, Synthetic Organic Chemistry, Medicinal chemistry, Research chemical, R&D chemical, Biotechnology, pesticide and dye intermediates. 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2 storage conditions: , transport conditions: . Certificate of Analysis (COA), safety data sheet (SDS) material safety data sheet (MSDS) is available for 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2. 12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1), 85209-91-2 Payment mode: NET 30, 60 days Credit / Debit / Purchase Order.